Bill > HB62

This bill suspends the implementation of House Bill 11 from the 2024 Kentucky legislative session, which relates to nicotine product regulation, pending a Supreme Court decision in the case Food and Drug Administration v. Wages and White Lion Investments. Specifically, the bill will only allow the provisions of HB 11 to be enforced if the Supreme Court rules that the Fifth Circuit Court of Appeals was incorrect in its decision regarding FDA denial orders. The suspension applies to several specific Kentucky Revised Statutes (KRS) sections related to nicotine products. The bill is retroactively effective to January 1, 2025, and contains an emergency clause that allows it to take effect immediately upon passage. The legislative intent appears to be waiting for a definitive Supreme Court ruling before imposing stricter regulations on nicotine products, ensuring that any new state regulations align with potential federal guidance or court interpretations of FDA actions.

Labor and Employment

https://apps.legislature.ky.gov/record/25RS/hb62.html